Literature DB >> 22709963

Global threat from drug resistant HIV in sub-Saharan Africa.

Raph L Hamers1, Cissy Kityo, Joep M A Lange, Tobias F Rinke de Wit, Peter Mugyenyi.   

Abstract

Mesh：

Year:  2012        PMID： 22709963     DOI： 10.1136/bmj.e4159

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  24 in total

Review 1.  Substandard/counterfeit antimicrobial drugs.

Authors:  Theodoros Kelesidis; Matthew E Falagas
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa.

Authors:  Benjamin Chimukangara; Ayesha B M Kharsany; Richard J Lessells; Kogieleum Naidoo; Soo-Yon Rhee; Justen Manasa; Tiago Gräf; Lara Lewis; Cherie Cawood; David Khanyile; Karidia Diallo; Kassahun A Ayalew; Robert W Shafer; Gillian Hunt; Deenan Pillay; Salim Karim Abdool; Tulio de Oliveira
Journal:  AIDS Res Hum Retroviruses       Date:  2019-01-07       Impact factor: 2.205

Review 3.  Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review.

Authors:  James H McMahon; Julian H Elliott; Silvia Bertagnolio; Rachel Kubiak; Michael R Jordan
Journal:  Bull World Health Organ       Date:  2013-02-21       Impact factor: 9.408

4.  Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.

Authors:  Marjorie Monleau; Avelin F Aghokeng; Sabrina Eymard-Duvernay; Anoumou Dagnra; Dramane Kania; Nicole Ngo-Giang-Huong; Coumba Touré-Kane; Lien X T Truong; Marie-Laure Chaix; Eric Delaporte; Ahidjo Ayouba; Martine Peeters
Journal:  J Clin Microbiol       Date:  2013-12-11       Impact factor: 5.948

Review 5.  Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.

Authors:  Richard J Lessells; Ava Avalos; Tulio de Oliveira
Journal:  AIDS Rev       Date:  2013 Oct-Dec       Impact factor: 2.500

6.  Development and evaluation of an affordable real-time qualitative assay for determining HIV-1 virological failure in plasma and dried blood spots.

Authors:  Susan C Aitken; Aletta Kliphuis; Michelle Bronze; Carole L Wallis; Cissy Kityo; Sheila Balinda; Wendy Stevens; Nicole Spieker; Tulio de Oliveira; Tobias F Rinke de Wit; Rob Schuurman
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

Review 7.  Are subtype differences important in HIV drug resistance?

Authors:  R J Lessells; D K Katzenstein; T de Oliveira
Journal:  Curr Opin Virol       Date:  2012-09-21       Impact factor: 7.090

8.  Implementation of a point mutation assay for HIV drug resistance testing in Kenya.

Authors:  Horacio A Duarte; Ingrid A Beck; Molly Levine; Catherine Kiptinness; James M Kingoo; Bhavna Chohan; Samah R Sakr; Michael H Chung; Lisa M Frenkel
Journal:  AIDS       Date:  2018-10-23       Impact factor: 4.177

9.  Combined antiretroviral and anti-tuberculosis drug resistance following incarceration.

Authors:  K E Stott; T de Oliviera; R J Lessells
Journal:  South Afr J HIV Med       Date:  2013-09-01       Impact factor: 2.744

10.  High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa.

Authors:  Justen Manasa; Richard J Lessells; Andrew Skingsley; Kevindra K Naidu; Marie-Louise Newell; Nuala McGrath; Tulio de Oliveira
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.